A. Wesley Burks

TL;DR: Extended-therapy peanut SLIT provided clinically meaningful desensitization in the majority of children with peanut allergy that was balanced with ease of administration and a favorable safety profile.

TL;DR: Gastrointestinal eosinophilia is present in approximately 10% of patients with EoE; the symptom-diagnosis time gap is influenced by age, race, food allergy, and atopic dermatitis; symptoms vary with race; concurrent infectious/immunologic disorders and mental health disorders are common; and the level of esophageal eOSinophils is comparable in patients with and without fibrostenotic features.

TL;DR: In the past decade, the ages of first peanut exposure and reaction have declined among peanut-allergic children seen in a referral clinic, and sesame seeds should perhaps be considered one of the major food allergens.

TL;DR: Treatment with intramuscular epinephrine continues to be the recommended first‐line therapy, although studies indicate that education of both the patients and the medical community is needed.

TL;DR: It is found that displacement of the actin cytoskeleton and its continued association with FcεRI impede the capacity of desensitized MCs to evoke the calcium response that is essential for MC degranulation.